Switzerland hosts some of its most valuable publicly traded companies, spanning pharmaceuticals, finance and more. Here we rank the ten largest Swiss-listed companies by market capitalisation, as of 17 April 2026 – defined as share price multiplied by the total number of outstanding shares, shown in Swiss francs.
Our table shows the top Swiss listings by market capitalisation in Swiss francs, together with their latest share price – as of 17 April 2026.
| Rank | Company | Market cap (USD) | Share price (USD) |
|---|---|---|---|
| 1 | Roche | $336.3bn | $422.64 |
| 2 | Novartis | $291.8bn | $151.19 |
| 3 | Nestlé | $259.5bn | $100.87 |
| 4 | ABB | $174.6bn | $96.19 |
| 5 | UBS | $139.8bn | $44.23 |
| 6 | Chubb | $128.7bn | $328.96 |
| 7 | Compagnie Financière Richemont | $120.5bn | $205.02 |
| 8 | Zurich Insurance Group | $107.3bn | $718.10 |
| 9 | Glencore | $87.9bn | $7.45 |
| 10 | TE Connectivity | $71bn | $241.72 |
The information on this page is based on publicly disclosed data from company filings and financial platforms. It is provided for informational purposes only and does not represent trading advice or a recommendation. Data is correct as of the stated date but may be updated without notice.
Switzerland consistently ranks among the world's most competitive economies, supported by political neutrality, a highly skilled workforce, low corporate tax rates, and a stable currency – topping the IMD World Competitiveness Ranking in 2025 (IMD Business School, 16 June 2025). The Swiss franc's safe-haven status means Swiss-listed multinationals often face currency headwinds when the franc strengthens – a persistent structural challenge for exporters such as Roche, Novartis, and Nestlé, whose revenues are generated mainly outside Switzerland; the franc appreciated by roughly 17% since January 2025, compressing margins across export-heavy industries (Invidis, 15 February 2026). The Swiss Market Index (SMI) closed at 13,426.72 on 17 April 2026, having recovered from early-year volatility linked to global trade tariff concerns (MarketScreener, 17 April 2026).
Switzerland's top 10 listed companies by market cap are concentrated in three dominant sectors: pharmaceuticals and healthcare (Roche, Novartis), consumer staples (Nestlé), and financials (UBS, Chubb, Zurich Insurance). This sector mix gives the Swiss equity market a relatively defensive character compared with peers such as Germany, which is more heavily weighted towards industrials and autos, or France, which has greater exposure to luxury and energy. The remaining companies – ABB (industrial automation), Richemont (luxury goods), Glencore (mining and commodities), and TE Connectivity (electronics and connectivity) – add cyclical diversification to the mix (CompaniesMarketCap, accessed 17 April 2026).
Swiss blue-chip companies have a strong tradition of consistent dividend payments and share buybacks, which can make them relevant to income-oriented investors. Roche raised its annual dividend for the 39th consecutive year at its March 2026 AGM, lifting the payout to CHF 9.80 per share (Roche, 10 March 2026). Nestlé's ex-dividend date fell on 20 April 2026, with shareholders of record on 21 April set to receive CHF 3.10 per share, payable 22 April (DividendMax, accessed 17 April 2026). UBS has also outlined plans to return capital to shareholders, although its dividend strategy remains contingent on the outcome of the Swiss Federal Council's anticipated capital requirements ruling in April 2026, with up to $26 billion in additional core capital potentially required following its 2023 acquisition of Credit Suisse (Bloomberg, 15 March 2026).
Corporate activity among Switzerland's largest companies has remained active in 2026. Novartis spent $30 billion on acquisitions and licensing deals in 2025 to offset biosimilar competition for Entresto, and is poised to complete a $12 billion takeover of RNA drug developer Avidity Biosciences in the coming months (Pharmaphorum, 20 April 2026). Glencore and Rio Tinto confirmed preliminary all-share merger discussions in January 2026 that would have created the world's largest mining company, valued at approximately $207 billion, but Rio Tinto walked away on 5 February 2026 after the two sides failed to agree on valuation (Reuters, 5 February 2026); Glencore CEO Gary Nagle subsequently confirmed he remains open to other high-value consolidation deals (MarketScreener, 18 February 2026). Meanwhile, Zurich Insurance tapped debt markets on 16 April 2026, successfully placing $500 million in dated subordinated notes maturing in October 2056 with a fixed annual coupon of 5.875% until October 2036 (Zurich Insurance Group, 16 April 2026).
Market capitalisation changes with share price movements, share buybacks, corporate actions, and new share issuance. Company announcements, sector trends, economic data and currency shifts can also affect investor sentiment and prices. Always remember that past performance is not a reliable indicator of future results.
To trade Swiss share CFDs, you’ll need a verified account with a regulated CFD provider, sufficient funds, and access to the trading platform. Contracts for difference (CFDs) are traded on margin, and leverage amplifies both profits and losses. Be sure you understand margin requirements, overnight financing charges, and spreads before entering any trades. Review each company carefully, use risk management tools such as take-profit and stop-loss orders, and consider practising with a demo account.
You may wish to research company fundamentals such as financial health, market position, and recent results. Large-cap stocks often provide greater liquidity, though they may still experience volatility. Keep your trading strategies simple, apply risk controls like stop-loss orders, avoid excessive leverage, bear in mind that past performance is not a reliable indicator of future results.
Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.
Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.
Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.
I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!
I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️
I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.
Love the TV integration. Makes traders life smooth and comfortable.
I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!
I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!
This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one
User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.
Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.
Why choose Capital.com? Our numbers speak for themselves
Capital.com Group
Ratings and Reviews
Ratings and Reviews